X T L Biopharmaceuticals reported $533K in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
X T L Biopharmaceuticals USD 533K 807K Jun/2025